[go: up one dir, main page]

NO892743L - Fremgangsmaate for fremstilling av farmakologisk aktive glycerol-derivater. - Google Patents

Fremgangsmaate for fremstilling av farmakologisk aktive glycerol-derivater.

Info

Publication number
NO892743L
NO892743L NO89892743A NO892743A NO892743L NO 892743 L NO892743 L NO 892743L NO 89892743 A NO89892743 A NO 89892743A NO 892743 A NO892743 A NO 892743A NO 892743 L NO892743 L NO 892743L
Authority
NO
Norway
Prior art keywords
procedure
preparation
pharmacologically active
glycerol derivatives
active glycerol
Prior art date
Application number
NO89892743A
Other languages
English (en)
Other versions
NO177495B (no
NO177495C (no
NO892743D0 (no
Inventor
Kazuo Okano
Osamu Asano
Naoyuki Shimomura
Tetsuya Kawahara
Shinya Abe
Shuhei Miyazawa
Mitsuaki Miyamoto
Hiroyuki Yoshimura
Koukichi Harada
Junsaku Nagaoka
Tsutomu Kawata
Tsutomu Yoshimura
Hiromasa Suzuki
Shigeru Souda
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of NO892743D0 publication Critical patent/NO892743D0/no
Publication of NO892743L publication Critical patent/NO892743L/no
Publication of NO177495B publication Critical patent/NO177495B/no
Publication of NO177495C publication Critical patent/NO177495C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/40Acylated substituent nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO892743A 1988-07-04 1989-07-03 Analogifremgangsmåte for fremstilling av terapeutisk aktive glyserinderivater NO177495C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP16638688 1988-07-04

Publications (4)

Publication Number Publication Date
NO892743D0 NO892743D0 (no) 1989-07-03
NO892743L true NO892743L (no) 1990-01-05
NO177495B NO177495B (no) 1995-06-19
NO177495C NO177495C (no) 1995-09-27

Family

ID=15830457

Family Applications (1)

Application Number Title Priority Date Filing Date
NO892743A NO177495C (no) 1988-07-04 1989-07-03 Analogifremgangsmåte for fremstilling av terapeutisk aktive glyserinderivater

Country Status (20)

Country Link
US (1) US5037827A (no)
EP (1) EP0353474B1 (no)
JP (1) JP2766319B2 (no)
KR (1) KR910006127B1 (no)
CN (1) CN1041920C (no)
AT (1) ATE120734T1 (no)
AU (1) AU621634B2 (no)
CA (1) CA1334753C (no)
DD (1) DD297814A5 (no)
DE (1) DE68922035T2 (no)
DK (1) DK329189A (no)
ES (1) ES2070148T3 (no)
FI (1) FI97883C (no)
GR (1) GR3015704T3 (no)
HU (2) HUT62855A (no)
NO (1) NO177495C (no)
NZ (1) NZ229789A (no)
PH (1) PH26045A (no)
PT (1) PT91051B (no)
RU (1) RU2040521C1 (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5136040A (en) * 1991-02-26 1992-08-04 Eli Lilly And Company Preparation of substituted tetrahydropyridines
US5700817A (en) * 1992-06-30 1997-12-23 Pohang Iron & Steel Co., Ltd. Cyclic lipid derivatives as potent PAF antagonists
DE69324342T2 (de) * 1992-06-30 1999-11-04 Pohang Iron & Steel Co. Ltd., Pohang City Neue cyclische lipidderivate als potente paf-antagonisten
JPH07285866A (ja) * 1994-02-22 1995-10-31 Eisai Co Ltd 臓器障害予防・治療・改善剤
US5854279A (en) * 1996-06-04 1998-12-29 Eisai Co., Ltd Therapeutic agent for dermatosis
US6177067B1 (en) 1996-08-09 2001-01-23 Shiseido Company, Ltd. Hair revitalizing tonic composition containing a 2,2-dimethylpropanediol compound and use thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0014778B1 (de) * 1979-02-19 1983-05-18 BBC Aktiengesellschaft Brown, Boveri & Cie. Zweistüfiges Abgasturboladeraggregat
DK160818C (da) * 1983-12-30 1991-10-07 Hoffmann La Roche N-ring-holdige glycerolderivater, fremgangsmaade til fremstilling deraf, anvendelse deraf til fremstilling af et blodpladeaktiveringsfaktorhaemmende middel samt laegemidler indeholdende en saadan forbindelse
ZA8410014B (en) * 1983-12-30 1985-08-28 Hoffmann La Roche Glycerol derivatives
US4737518A (en) * 1984-04-03 1988-04-12 Takeda Chemical Industries, Ltd. Lipid derivatives, their production and use
DE3586746D1 (de) * 1984-04-03 1992-11-19 Takeda Chemical Industries Ltd Lipidderivate, ihre produktion und verwendung.
US4863941A (en) * 1985-06-18 1989-09-05 Hoffmann-La Roche Inc. Glycerol derivatives
JPH0815643B2 (ja) * 1988-05-19 1996-02-21 新日本製鐵株式会社 幅可変薄スラブ連続鋳造機の湯面レベル制御方法

Also Published As

Publication number Publication date
EP0353474A2 (en) 1990-02-07
PT91051B (pt) 1995-06-30
HUT62855A (en) 1993-06-28
JP2766319B2 (ja) 1998-06-18
NO177495B (no) 1995-06-19
PT91051A (pt) 1990-02-08
DK329189A (da) 1990-01-05
ES2070148T3 (es) 1995-06-01
FI893099L (fi) 1990-01-05
KR900001654A (ko) 1990-02-27
HU208119B (en) 1993-08-30
GR3015704T3 (en) 1995-07-31
RU2040521C1 (ru) 1995-07-25
DK329189D0 (da) 1989-07-03
CA1334753C (en) 1995-03-14
FI97883C (fi) 1997-03-10
HUT52478A (en) 1990-07-28
DE68922035T2 (de) 1995-09-14
DD297814A5 (de) 1992-01-23
KR910006127B1 (ko) 1991-08-13
AU621634B2 (en) 1992-03-19
NZ229789A (en) 1991-04-26
CN1041920C (zh) 1999-02-03
NO177495C (no) 1995-09-27
NO892743D0 (no) 1989-07-03
EP0353474B1 (en) 1995-04-05
ATE120734T1 (de) 1995-04-15
JPH02131467A (ja) 1990-05-21
DE68922035D1 (de) 1995-05-11
HU9202211D0 (en) 1992-12-28
PH26045A (en) 1992-01-29
US5037827A (en) 1991-08-06
AU3721389A (en) 1990-01-04
EP0353474A3 (en) 1991-03-27
FI893099A0 (fi) 1989-06-26
CN1039414A (zh) 1990-02-07
FI97883B (fi) 1996-11-29

Similar Documents

Publication Publication Date Title
NO159017C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,2,3,4-tetrahydroisokinolin-3-karboksylsyre-derivater.
NO912410L (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocyklen-derivater.
NO851054L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 3-substituerte 2-oksindol-1-karbokamider
FR2630328B1 (fr) Derive de l'histamine, sa preparation et son application en therapeutique
DE3665711D1 (de) Novel guanidinomethylbenzoic acid derivatives
NO881835L (no) Fremgangsmaate for fremstilling av terapeutisk aktive bicykliske forbindelser.
ES2055235T3 (es) Composicion anti-inflamatoria y/o antialergica que comprende derivados de glutation.
NO892743D0 (no) Fremgangsmaate for fremstilling av farmakologisk aktive glycerolderivater.
NO169648C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive arakidonsyre-derivater
DE69019404D1 (de) Derivate von Penciclovir zur Behandlung von Hepatitis-B-Infektionen.
DK707988D0 (da) Fremgangsmaade til at haemme virus
NO173991C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,2,5-ditiazocin-derivater
NO172541C (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyridoindol-derivater
FR2618436B1 (fr) Derives de piperidine, leur preparation et leur application en therapeutique
NO894325D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrrolidin-derivater.
NO171639C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazolpyrazolderivater
NO167982C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive penemderivater.
ES2042727T3 (es) Acidos 1,3,4,9-tetrahidropirano(3,4-b)indol-1-acetico.
ATE95697T1 (de) Uricosuretische zusammensetzung.
DE69102389D1 (de) Verwendung eines benzo[b]thiophen-2-carboximidamid-Derivates gegen Herzinsuffizienz.
DE3889532D1 (de) Dihydropyridin-Verbindung zur Verbesserung der Adernausdehnung und Hemmung der Herzhypertrophie.
ATE81466T1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur prophylaxe und zur behandlung von herzinsuffizienz.
DE3782229D1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.